Value-based insurance design in medicare

William Encinosa ()

Applied Health Economics and Health Policy, 2009, vol. 7, issue 3, 149-154

Abstract: Drug benefits have responded to the rise in drug costs by increasing patient cost sharing. However, many now realize that increasing cost sharing for high-value preventive-care drugs can be detrimental in terms of reducing patient drug adherence and causing increased inpatient and outpatient costs. Value-based insurance design (VBID) deals with this by decreasing the co-payments for high-value preventive-care drugs and raising copayments for drugs with less value. The Medicare Part D drug benefit in the US could benefit greatly from VBID, especially since the Part D stand-alone plans currently have no incentive to reduce inpatient and outpatient costs. While VBID will improve outcomes and avert hospitalizations, it will not result in net cost savings since high drug prices usually overwhelm any inpatient and outpatient cost offsets. Thus, for VBID to reap net cost savings, it must be combined with value-based purchasing of drugs, and it must move beyond just the lowering of copayments and increase incentives by giving rebates to patients so that they can share in the cost savings of improved drug adherence. Copyright Adis Data Information BV 2009

Date: 2009
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1007/BF03256148 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:7:y:2009:i:3:p:149-154

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/BF03256148

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().